The American Cancer Society’s Cancer Statistics, 2026 report highlights a historic milestone: the 5-year relative survival ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

A recent study published in the journal Frontiers in Endocrinology investigated the role of the short-chain dehydrogenase/reductase 42E member 1 (SDR42E1) enzyme in regulating sterol metabolism and ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Novel use of clinical pathways to improve clinical trial accrual. Exploring the use of health information technology in the awareness of genetic testing among individuals with a family history of ...

The field of Integrative Oncology (IO) harmonizes evidence-based complementary practices with conventional cancer care to ...

Despite the significance of immune checkpoint inhibitors (ICIs) in solid tumor treatment, identifying ICI-sensitive populations remains a challenge. Mutations in DNA damage response (DDR) pathway ...

New research shows that physical pressure from brain tumors or injuries triggers a "self-destruction" program in neurons, leading to irreversible brain damage.

Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study ...

Somerset NHS launches England’s first breast cancer self-referral pathway via NHS 111, enabling faster specialist access and earlier diagnosis for patients.